Cnidoscolus aconitifolius (Mill.) I.M.Johnstone is a medicinal plant widely used in ethnomedicine for the treatment of cancer, and other diseases. The effects of the methanol extracts of the leaf, stem, and root barks were evaluated on the breast (MCF-7), and lung (NCI-H460) cancer cells at 1-250 µg/mL using SRB assay and the extracts were screened for phytochemicals using standard method. The stem and root extracts showed no activity at the maximum concentration, while the leaf extract at 100 µg/mL showed a remarkable cell growth inhibition against breast (-14.50 ± 0.58), and lung cancer (+53.29 ± 4.57 %) in vitro. The extracts showed the presence of saponins, terpenes, cardiac glycosides, and phenolic compounds.
INTRODUCTION
Traditionally, medicinal plants have found applications in the formulation and production of modern drugs. These are used in the treatment of severe life threatening ailments including cancer especially in developing countries. Cnidoscolus aconitifolius (Euphorbiaceae) originates from South East Mexico and Guatamela and in South Western part of Nigeria. 2 It is locally known as Iyana Ipaja. 3 In Nigerian traditional health practices, it is also referred as "Hospital too far" due to its rapid healing properties against certain health conditions. 4 In ethnomedicine, it has been reported to have blood boosting effect in both pregnant and young anaemic children 5 , and as an antidote for alcoholism, insomnia, and scorpion bite. Previously, the cytotoxic and anti-proliferative activity of the methanol extracts of C. aconitifolius leaves, stem, and root barks against tadpoles of Ranicep ranninus and radicle length of Sorghum bicolor have been reported. 6 The cytotoxicity of ethanol extract of its leaf against Brine Shrimp has also been noted. 7 However, there is presently no report for the anticancer activity of this plant. Therefore, present study was aimed at validating the antitumor ethnomedicinal uses of Cnidoscolus aconitifolius by using human breast, and lung cancer cell air dried in the laboratory for 5 days at room temperature, followed by oven drying at 40°C and subsequently grinded to a powder form and stored in an air tight container.
Extraction of plant materials
About 2.5 kg of each plant part was exhaustively extracted in methanol (95%) using a Soxhlet apparatus, and dried using a rotary evaporator maintained at 40C.
Preliminary phytochemical screening
Phytochemical screenings of the extracts (leaves stem and root barks) were carried out using standard methods previously described. 
Sulforhodamine-B assay
The growth inhibitory activities of methanol extract of Cnidoscolus acontifolius and its fractions were performed using human cancer cell lines [breast (MCF-7) and lung cancer (NCI-H460)]. 9 The stock solutions of plant extracts and fractions were prepared as 40 mg/mL in DMSO.
However, doxorubicin (1 mM) was prepared in distilled water. On the experimental day, respective dilutions were prepared in RPMI-1640 containing gentamicin (50 µg/mL). plates. These were left at room temperature for 30 min, washed (3x) and dried overnight. After 48 h, experimental plates were also fixed in similar manner.
The dried fixed plates were stained with 100 µL of sulforhodamine solution (0.4 % wt/vol prepared in 1 % acetic acid) for 10 min, followed by washing (5x) with 1 % acetic acid to remove excess stain and air-dried. Finally, 100 µL of tris base solution (pH 10.2, 10 mM) was added to solubilize protein bound stain and absorbance was recorded at 545 nm using a microplate reader. All the experiments were conducted in triplicates. The results of the extracts and fractions were presented as GI50, TGI and LC50 (μg/mL) values.
Fractionation of methanol extract of the leaf of C. aconitifolius
About 25.0 g of the crude methanol extract were re-dissolved in methanol-water (1:1) and partitioned exhaustively with chloroform (400 mL ×4) volumes in a separating funnel. The chloroform layer (lower) was collected first, followed by the aqueous fraction. This was repeated until a clear lower layer was obtained. The aqueous and the chloroform fractions were concentrated to dryness on a rotary evaporator and their respective yields noted. 
Results of the effect of the methanol extracts on MCF-7 and NCI-H460 cell lines
The methanol extract of leaves produced growth inhibitory and cytotoxic effects on MCF-7 to varying extents. At a concentration of 50 μg/mL, the extract had +63.08 ± 3.63 % growth inhibition which became more cytotoxic at 200 and 250 μg/mL as -14.70 ± 0.76, and -26.25 ± 2.18 % were recorded. The GI50 and TGI were recorded as 26.67 ± 3.33, and 95 μg/mL while the LC50 noted to be greater than 250 μg/mL (Table 2) were recorded in a concentration dependent manner against human lung cancer cell line (NCI-H460). The GI50 value of ~59.67 µg/mL was recorded, the LC50 and TGI were observed to be greater than 250 µg/mL (Table 3 ). Control absorbance in MCF-7 at 545 nm = 1.9 ± 0.1 Each value represents % mean ± SEM of three independent experiments as compared to control. Growth inhibition = + and cytotoxicity = -; GI50 and TGI = Concentration of drug causing 50% and 100 % growth inhibition of cells. LC50 = Lethal concentration of drug that killed 50% cells. The order of activity was significantly different from each other. Control absorbance in NCI-H460 at 545 nm = 2. 0 ± 0.1 Each value represents % mean ± SEM of three independent experiments as compared to control. Growth inhibition = + and cytotoxicity = -; GI50 and TGI = Concentration of drug causing 50 % and 100 % growth inhibition of cells. LC50 = Lethal concentration of drug that killed 50% cells. The order of activity was significantly different from each other.
Extract

Effects of the aqueous and chloroform fractions of C. aconitifolius against breast (MCF-7)
and lung cancer (NCI-H460) cell lines.
The chloroform fraction at 25 µg/mL displayed a significant growth inhibiton ~48.62 % against MCF-7 cells which became cytotoxic at 50-100 µg/mL in a concentration dependent manner with GI50, LC50, and TGI of 22.50 , 68.75, and 43.75 µg/mL, respectively (Table 4) .
Similar effects were also observed by the chloroform fraction against NCI-H460 cells, giving GI50 and TGI of 35.40 55.8 µg/mL with LC50 ˃100 µg/mL. The aqueous fraction did not show any activity at 100 µg/mL on both cell lines (Table 5 ).
u n c o r r e c t e d p r o o f 
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The global burden of this disease has continued to surge due to the adoption of high level of cancer inducing life styles such as smoking, eating of westernized diet, and physical inactivity .
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According to the global cancer statistics, breast and lung cancers are the most frequently diagnosed cancer in females and males, respectively.
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The commonly employed treatment includes chemotherapy, radiotherapy and in some cases, surgery which also exhibit series of side effects among patients. 13 Due to this, research into ethno-medicinal plants with antitumor properties as an alternative medicine at the early stage of the disease has become necessary.
Phytochemical screening of the extracts revealed the presence of various phytochemicals including tannins and flavonoids which are known to possess free radicals scavenging activity, hence prevent the development diseases. The higher activity demonstrated by the leaf extract over the stem and root extracts could be due to the abundance of one or more secondary metabolites such as terpenes and phenolic compounds, which are known for their anti-free radical potentials and inhibition of carcinogenesis. 14, 15 Our previous work has demonstrated that the extracts from leaf, stem and root barks of The leaf extract exhibited a concentration dependent effect with higher growth inhibitory effect against breast cancer by ~2x than that of lung cancer cells. Partitioning of the extract was observed to increase the activity compared to the crude as the chloroform fraction at 100 µg/mL produces cytotoxicities of -72 ±9.1 and -22 ±11 % as well as GI50 of 22.5 and 35µg/mL against MCF-7 and NCI-H460 cells respectively. This variation in sensitivities of the crude extracts and fraction could be as a result of the interference of some molecular process at some stages in the cell division processes e.g. the G2/M phase and the induction of some apoptotic process such as mitochondrial trans-membrane depolarization. 14 The results obtained have validated the traditional uses of this plant in the treatment cancer.
However, further work towards the isolation of the constituents responsible for the observed activities is required.
